Cargando…
Enhancing the efficacy of (131)I therapy in non-toxic multinodular goitre with appropriate use of methimazole: an analysis of randomized controlled study
PURPOSE: It is possible to raise the rate of the uptake of (131)I in the thyroid gland (RAIU) by increasing the endogenous TSH level through appropriate use of methimazole (MMI) prior to (131)I therapy. The purpose of this paper is to assess the impact of pre treatment with MMI on the efficacy of (1...
Autores principales: | Szumowski, Piotr, Abdelrazek, Saeid, Sykała, Monika, Mojsak, Małgorzata, Żukowski, Łukasz, Siewko, Katarzyna, Maliszewska, Katarzyna, Adamska, Agnieszka, Popławska-Kita, Anna, Krętowski, Adam, Myśliwiec, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969001/ https://www.ncbi.nlm.nih.gov/pubmed/31586293 http://dx.doi.org/10.1007/s12020-019-02100-x |
Ejemplares similares
-
Dosimetry during adjuvant (131)I therapy in patients with differentiated thyroid cancer-clinical implications
por: Szumowski, Piotr, et al.
Publicado: (2021) -
Efficacy of (99m)Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease
por: Szumowski, Piotr, et al.
Publicado: (2019) -
Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
por: Sykała, Monika, et al.
Publicado: (2021) -
Oxidative stress and radioiodine treatment of differentiated thyroid cancer
por: Buczyńska, Angelika, et al.
Publicado: (2021) -
The Relationship between Oxidative Status and Radioiodine Treatment Qualification among Papillary Thyroid Cancer Patients
por: Buczyńska, Angelika, et al.
Publicado: (2023)